Gene · 3455
Papers3,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression of interferon-stimulated genes, but not polymorphisms in the interferon α/β receptor 2 gene, is associated with coronavirus disease 2019 mortality. | Heliyon | 2024 | 39435115 | PubTator, text mining | PubMed |
| CNS disease associated with enhanced type I interferon signalling. | Lancet Neurol | 2024 | 39424561 | PubTator, text mining | PubMed |
| A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice. | Nat Commun | 2024 | 39414822 | PubTator, text mining | PubMed |
| pK205R targets the proximal element of IFN-I signaling pathway to assist African swine fever virus to escape host innate immunity at the early stage of infection. | PLoS Pathog | 2024 | 39405340 | PubTator, text mining | PubMed |
| Association of IFNAR2 and TYK2 with COVID-19 pathology: current and future. | Front Immunol | 2024 | 39351231 | PubTator, text mining | PubMed |
| GWAS-Identified Loci are Associated with Obesity and Type 2 Diabetes Mellitus in Patients with Severe COVID-19. | Front Biosci (Schol Ed) | 2024 | 39344392 | PubTator, text mining | PubMed |
| Yield of genetic association signals from genomes, exomes and imputation in the UK Biobank. | Nat Genet | 2024 | 39322778 | PubTator, text mining | PubMed |
| A sensitive assay for measuring whole-blood responses to type I IFNs. | Proc Natl Acad Sci U S A | 2024 | 39312669 | PubTator, text mining | PubMed |
| Genomic insight into COVID-19 severity in MAFLD patients: a single-center prospective cohort study. | Front Genet | 2024 | 39296547 | PubTator, text mining | PubMed |
| Transcriptional control of interferon-stimulated genes. | J Biol Chem | 2024 | 39276937 | PubTator, text mining | PubMed |
| IFN Receptor 2 Regulates TNF-α-Mediated Damaging Inflammation during Aspergillus Pulmonary Infection. | J Immunol | 2024 | 39212415 | PubTator, text mining | PubMed |
| GWAS-significant loci and severe COVID-19: analysis of associations, link with thromboinflammation syndrome, gene-gene, and gene-environmental interactions. | Front Genet | 2024 | 39175753 | PubTator, text mining | PubMed |
| Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD. | Respir Res | 2024 | 39160551 | PubTator, text mining | PubMed |
| Impact of Genomic Mutation on Melanoma Immune Microenvironment and IFN-1 Pathway-Driven Therapeutic Responses. | Cancers (Basel) | 2024 | 39061208 | PubTator, text mining | PubMed |
| OIP5-AS1 enhances the malignant characteristics and resistance to chemotherapy of pancreatic cancer cells by targeting miR-30d-5p/MARCH8. | Heliyon | 2024 | 39050450 | PubTator, text mining | PubMed |
| Genetic predisposition to milder forms of COVID-19 may provide some resilience to head and neck cancers. | Front Oncol | 2024 | 39040446 | PubTator, text mining | PubMed |
| Stratified analyses refine association between TLR7 rare variants and severe COVID-19. | HGG Adv | 2024 | 38944683 | PubTator, text mining | PubMed |
| Feasibility of Using a Type I IFN-Based Non-Animal Approach to Predict Vaccine Efficacy and Safety Profiles. | Vaccines (Basel) | 2024 | 38932312 | PubTator, text mining | PubMed |
| Exploring the protective association between COVID-19 infection and laryngeal cancer: insights from a Mendelian randomization study. | Front Immunol | 2024 | 38915416 | PubTator, text mining | PubMed |
| SENP6 restricts the IFN-I-induced signaling pathway and antiviral activity by deSUMOylating USP8. | Cell Mol Immunol | 2024 | 38906982 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3455/papers?page=7